WO2002085311A3 - Formulation de gonadotropine chorionique humaine - Google Patents
Formulation de gonadotropine chorionique humaine Download PDFInfo
- Publication number
- WO2002085311A3 WO2002085311A3 PCT/US2002/013269 US0213269W WO02085311A3 WO 2002085311 A3 WO2002085311 A3 WO 2002085311A3 US 0213269 W US0213269 W US 0213269W WO 02085311 A3 WO02085311 A3 WO 02085311A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- methods
- relates
- hcg
- peptide
- composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/113—Multiple emulsions, e.g. oil-in-water-in-oil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
- A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Virology (AREA)
- Dermatology (AREA)
- Endocrinology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Immunology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Molecular Biology (AREA)
- AIDS & HIV (AREA)
- Reproductive Health (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP02764353A EP1390053A2 (fr) | 2001-04-25 | 2002-04-25 | Formulation de gonadotropine chorionique humaine |
JP2002582887A JP2004529147A (ja) | 2001-04-25 | 2002-04-25 | hCG処方 |
AU2002338436A AU2002338436A1 (en) | 2001-04-25 | 2002-04-25 | Hcg formulation |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US28593901P | 2001-04-25 | 2001-04-25 | |
US60/285,939 | 2001-04-25 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2002085311A2 WO2002085311A2 (fr) | 2002-10-31 |
WO2002085311A3 true WO2002085311A3 (fr) | 2003-08-21 |
Family
ID=23096335
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2002/013269 WO2002085311A2 (fr) | 2001-04-25 | 2002-04-25 | Formulation de gonadotropine chorionique humaine |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP1390053A2 (fr) |
JP (1) | JP2004529147A (fr) |
CN (1) | CN1512890A (fr) |
AU (1) | AU2002338436A1 (fr) |
WO (1) | WO2002085311A2 (fr) |
ZA (1) | ZA200309136B (fr) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7846898B2 (en) | 2004-02-13 | 2010-12-07 | Stem Cell Therapeutics Corp. | Pheromones and the luteinizing hormone for inducing proliferation of neural stem cells and neurogenesis |
US20150038413A1 (en) | 2006-02-03 | 2015-02-05 | Opko Biologics Ltd. | Long-acting polypeptides and methods of producing and administering same |
US7553940B2 (en) * | 2006-02-03 | 2009-06-30 | Modigene Inc | Long-acting EPO polypeptides and derivatives thereof and methods thereof |
US8946155B2 (en) | 2006-02-03 | 2015-02-03 | Opko Biologics Ltd. | Long-acting polypeptides and methods of producing and administering same |
US8048849B2 (en) | 2006-02-03 | 2011-11-01 | Modigene, Inc. | Long-acting polypeptides and methods of producing same |
US10221228B2 (en) | 2006-02-03 | 2019-03-05 | Opko Biologics Ltd. | Long-acting polypeptides and methods of producing and administering same |
US20140113860A1 (en) | 2006-02-03 | 2014-04-24 | Prolor Biotech Ltd. | Long-acting polypeptides and methods of producing and administering same |
US9249407B2 (en) | 2006-02-03 | 2016-02-02 | Opko Biologics Ltd. | Long-acting coagulation factors and methods of producing same |
US10351615B2 (en) | 2006-02-03 | 2019-07-16 | Opko Biologics Ltd. | Methods of treatment with long-acting growth hormone |
WO2009149307A2 (fr) * | 2008-06-04 | 2009-12-10 | San Diego State University Research Foundation | Compositions et procédés pour rétablir la fonction de transfert d’électron mitochondrial |
US9663778B2 (en) | 2009-07-09 | 2017-05-30 | OPKO Biologies Ltd. | Long-acting coagulation factors and methods of producing same |
DE102009056871A1 (de) * | 2009-12-03 | 2011-06-22 | Novartis AG, 4056 | Impfstoff-Adjuvantien und verbesserte Verfahren zur Herstellung derselben |
RU2463066C1 (ru) * | 2011-08-19 | 2012-10-10 | Государственное бюджетное образовательное учреждение высшего профессионального образования "Санкт-Петербургский государственный медицинский университет имени академика И.П. Павлова" Министерства здравоохранения и социального развития Российской Федерации | Фармакологическая антимикробная композиция пролонгированного действия |
BR112014025951A2 (pt) | 2012-04-19 | 2017-07-11 | Opko Biologics Ltd | variantes de oxintomodulina de longa ação e métodos de produção do mesmo |
BR112015011583B1 (pt) | 2012-11-20 | 2023-03-14 | Opko Biologics Ltd | Métodos para aumentar o tamanho ou volume hidrodinâmico de hormônio de crescimento humano, método para aumentar o peso molecular aparente de um polipeptídeo e método para aumentar a meia-vida de um polipeptídeo |
US20150065426A1 (en) * | 2013-08-27 | 2015-03-05 | Professional Compounding Centers Of America | Testosterone Booster Transdermal Compositions |
US20150158926A1 (en) | 2013-10-21 | 2015-06-11 | Opko Biologics, Ltd. | Long-acting polypeptides and methods of producing and administering same |
JP2018507227A (ja) | 2015-03-03 | 2018-03-15 | キュアポート インコーポレイテッド | 二薬搭載リポソーム医薬製剤 |
US9895313B2 (en) | 2015-03-03 | 2018-02-20 | Cureport, Inc. | Combination liposomal pharmaceutical formulations |
IL301728A (en) | 2015-06-19 | 2023-05-01 | Opko Biologics Ltd | Long-term coagulation factors and methods for their preparation |
CA3030533A1 (fr) | 2016-07-11 | 2018-01-18 | Oren HERSHKOVITZ | Facteur vii de coagulation a action prolongee et procedes de production associes |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4691006A (en) * | 1983-03-04 | 1987-09-01 | Ohio State University | Antigenic modification of polypeptides |
US5811390A (en) * | 1995-08-22 | 1998-09-22 | Metatron, Inc. | Use of beta HCG for the control of retroviral infection |
-
2002
- 2002-04-25 JP JP2002582887A patent/JP2004529147A/ja active Pending
- 2002-04-25 AU AU2002338436A patent/AU2002338436A1/en not_active Abandoned
- 2002-04-25 CN CNA028109368A patent/CN1512890A/zh active Pending
- 2002-04-25 EP EP02764353A patent/EP1390053A2/fr not_active Withdrawn
- 2002-04-25 WO PCT/US2002/013269 patent/WO2002085311A2/fr not_active Application Discontinuation
-
2003
- 2003-11-25 ZA ZA200309136A patent/ZA200309136B/xx unknown
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4691006A (en) * | 1983-03-04 | 1987-09-01 | Ohio State University | Antigenic modification of polypeptides |
US5811390A (en) * | 1995-08-22 | 1998-09-22 | Metatron, Inc. | Use of beta HCG for the control of retroviral infection |
Also Published As
Publication number | Publication date |
---|---|
WO2002085311A2 (fr) | 2002-10-31 |
JP2004529147A (ja) | 2004-09-24 |
EP1390053A2 (fr) | 2004-02-25 |
ZA200309136B (en) | 2005-10-26 |
AU2002338436A1 (en) | 2002-11-05 |
CN1512890A (zh) | 2004-07-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2002085311A3 (fr) | Formulation de gonadotropine chorionique humaine | |
EP2325205A3 (fr) | Cristaux d'anticorps complets et de fragments correspondants et leurs procédés de fabrication et d'utilisation | |
EP1568373A3 (fr) | Induction de reponses immunes cellulaires a HER2/neu a l'aide de compositions renfermant des peptides et des acides nucleiques | |
WO2003002136A3 (fr) | Formulation stable de glp-1 modifie | |
SI1887016T1 (sl) | Fragmenti človeškega horijevega gonadotropina (hcg) kot imunoregulator | |
WO1999010375A3 (fr) | Vaccin | |
GB0100758D0 (en) | Immunogenic complex method of preparation thereof and pharmaceutical compositions containing the same, useful for disease control | |
WO2003030934A3 (fr) | Formulations cpg et procedes y relatifs | |
WO2005007185A3 (fr) | Formulation destinee a un agent pharmaceutique proteique ne contenant pas d'albumine serique humaine ajoutee (hsa) | |
PT1171143E (pt) | Extracto peptidico de tremoco e composicao farmaceutica ou cosmetica ou nutraceutica compreendendo o referido extracto | |
BR0207283A (pt) | Anticorpos anti-egfr modificados com imunogenicidade reduzida | |
WO1998055495A3 (fr) | Oligonucleotides immunostimulateurs, compositions correspondantes et leurs procedes d'utilisation | |
WO2003028757A1 (fr) | Nouvelle methode pour induire des lymphocytes t specifiques d'antigenes | |
WO2002097393A3 (fr) | Tensioactifs clivables et procedes d'utilisation associes | |
NO20054440L (no) | Flytende formuleringer av tumornekrosefaktorbindende proteiner | |
WO2002055098A3 (fr) | Methode pour conferer un temps de latence a des substances pharmaceutiquement actives | |
EP2292255A3 (fr) | Proteines thérapeutiques stables | |
WO2005007673A3 (fr) | Peptides immunogenes | |
RS20050737A (en) | Liquid pharmaceutical formulations fish and lh together with a non- ionic surfactant | |
WO2002044197A3 (fr) | Peptides de fixation des recepteurs des cytokines | |
WO2002005830A3 (fr) | Extraits de plantes a photosynthese de type 'cam' et leurs utilisations | |
EP1801123A3 (fr) | Cristaux d'anticorps complets et de fragments correspondants et leurs procédés de fabrication et d'utilisation | |
WO2001040313A3 (fr) | Proteines immunoregulatrices felines, molecules d'acide nucleique et leurs utilisations | |
EP1364657A4 (fr) | Remedes contre les tumeurs affectant les organes hematopoietiques | |
WO2003093298A3 (fr) | Peptides immunogenes |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 02810936.8 Country of ref document: CN |
|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2002582887 Country of ref document: JP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2002764353 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 2002764353 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 2002764353 Country of ref document: EP |